|
SE352811B
(https=)
|
1971-06-04 |
1973-01-15 |
Pharmacia Ab |
|
|
US3960150A
(en)
|
1971-09-09 |
1976-06-01 |
Alza Corporation |
Bioerodible ocular device
|
|
US3867519A
(en)
|
1972-04-27 |
1975-02-18 |
Alza Corp |
Bioerodible drug delivery device
|
|
SE375007B
(https=)
|
1972-11-30 |
1975-04-07 |
Pharmacia Ab |
|
|
US3963025A
(en)
|
1974-09-16 |
1976-06-15 |
Alza Corporation |
Ocular drug delivery device
|
|
JPS5825980B2
(ja)
|
1976-02-12 |
1983-05-31 |
ヤマサ醤油株式会社 |
サイクリックヌクレオチドの定量法
|
|
US4209514A
(en)
*
|
1977-06-24 |
1980-06-24 |
Ciba-Geigy Corporation |
3-Aminoalkyl-4-aryl-tetrahydroazepines
|
|
US4186184A
(en)
|
1977-12-27 |
1980-01-29 |
Alza Corporation |
Selective administration of drug with ocular therapeutic system
|
|
US4303637A
(en)
|
1980-04-04 |
1981-12-01 |
Alza Corporation |
Medication indicated for ocular hypertension
|
|
DK231088D0
(da)
|
1988-04-28 |
1988-04-28 |
Ferrosan As |
Piperidinforbindelser, deres fremstilling og anvendelse
|
|
US5086063A
(en)
|
1988-03-28 |
1992-02-04 |
Du Pont Merck Pharmaceutical Company |
4-aryl-4-piperidine (or pyrrolidine or hexahydroazepine) carbinols and heterocyclic analogs thereof
|
|
CA1337418C
(en)
*
|
1988-03-28 |
1995-10-24 |
Engelbert Ciganek |
4-aryl-4-piperiding (or pyrrolidine or hexahydroazepine) carbinols and heterocyclic analogs thereof
|
|
US5401629A
(en)
|
1990-08-07 |
1995-03-28 |
The Salk Institute Biotechnology/Industrial Associates, Inc. |
Assay methods and compositions useful for measuring the transduction of an intracellular signal
|
|
US5443505A
(en)
|
1993-11-15 |
1995-08-22 |
Oculex Pharmaceuticals, Inc. |
Biocompatible ocular implants
|
|
US5869079A
(en)
|
1995-06-02 |
1999-02-09 |
Oculex Pharmaceuticals, Inc. |
Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
|
|
EP1164118B1
(en)
|
1995-12-04 |
2004-09-29 |
Tosoh Corporation |
Process for producing benzyl alcohol
|
|
NZ325914A
(en)
|
1996-03-29 |
1999-09-29 |
Pfizer |
Benzyl(idene)-lactam derivatives and salts thereof, their preparation and their use as selective (ant)agonists of 5-ht1a and/or 5-ht1d receptors and thus are effective as psychotherapeutic agents
|
|
EP0912513A1
(en)
|
1996-06-28 |
1999-05-06 |
Merck & Co., Inc. |
Fibrinogen receptor antagonist prodrugs
|
|
AU4064597A
(en)
|
1996-08-16 |
1998-03-06 |
Du Pont Pharmaceuticals Company |
Amidinophenyl-pyrrolidines, -pyrrolines, and -isoxazolidines and derivatives thereof
|
|
JP2002519326A
(ja)
*
|
1998-06-30 |
2002-07-02 |
イーライ・リリー・アンド・カンパニー |
セロトニン関連系に効果を有するアゼピン誘導体
|
|
CN1147483C
(zh)
|
1999-04-09 |
2004-04-28 |
阿斯特拉曾尼卡有限公司 |
金刚烷衍生物
|
|
WO2001032178A1
(en)
|
1999-10-29 |
2001-05-10 |
Novo Nordisk A/S |
Use of 3,4-substituted piperidines
|
|
GB0015562D0
(en)
|
2000-06-23 |
2000-08-16 |
Pfizer Ltd |
Heterocycles
|
|
WO2002000651A2
(en)
|
2000-06-27 |
2002-01-03 |
Bristol-Myers Squibb Pharma Company |
Factor xa inhibitors
|
|
US20020077323A1
(en)
|
2000-07-12 |
2002-06-20 |
Mclean Stafford |
Use of delta opioid receptor ligands and serotonin reuptake inhibitors in the treatment of chemical dependencies
|
|
US6476046B1
(en)
|
2000-12-04 |
2002-11-05 |
Sepracor, Inc. |
Diazabicyclo[4.3.0]nonanes, and methods of use thereof
|
|
ES2194588B1
(es)
|
2001-07-13 |
2004-10-16 |
Astur Pharma S.A. |
Precursores opticamente puros de paroxetina.
|
|
US6995144B2
(en)
|
2002-03-14 |
2006-02-07 |
Eisai Co., Ltd. |
Nitrogen containing heterocyclic compounds and medicines containing the same
|
|
KR101025633B1
(ko)
|
2002-09-19 |
2011-03-30 |
일라이 릴리 앤드 캄파니 |
오피오이드 수용체 안타고니스트로서의 디아릴 에테르
|
|
JP2006517567A
(ja)
|
2003-02-12 |
2006-07-27 |
ニューロサーチ、アクティーゼルスカブ |
新規８−アザ−ビシクロ［３．２．１］オクタン誘導体及びこれをモノアミン神経伝達物質再取り込み阻害薬として使用する方法
|
|
DE10308350B4
(de)
|
2003-02-27 |
2006-06-01 |
Sanofi-Aventis Deutschland Gmbh |
Verfahren zur Herstellung der enantiomeren Formen von cis-konfigurierten 1,3-Cyclohexandiol-Derivaten
|
|
WO2005012716A1
(en)
|
2003-07-25 |
2005-02-10 |
Siemens Vdo Automotive Inc. |
Integrated vapor control valve and sensor
|
|
US7468437B2
(en)
|
2003-09-30 |
2008-12-23 |
Merck & Co., Inc. |
Phenyl pyrrolidine ether tachykinin receptor antagonists
|
|
GB0327740D0
(en)
|
2003-11-28 |
2003-12-31 |
Glaxo Group Ltd |
Novel compounds
|
|
WO2005068427A1
(ja)
|
2004-01-14 |
2005-07-28 |
Takeda Pharmaceutical Company Limited |
カルボキサミド誘導体およびその用途
|
|
JP4224115B2
(ja)
|
2004-04-14 |
2009-02-12 |
ワイス |
ラパマイシン４２−エステル誘導体の位置特異的合成
|
|
DK1761519T3
(da)
|
2004-06-21 |
2008-07-21 |
Hoffmann La Roche |
Indolderivater som histaminreceptorantagonister
|
|
ATE478864T1
(de)
|
2004-07-16 |
2010-09-15 |
Schering Corp |
Hydantoinderivate zur behandlung von entzündlichen erkrankungen
|
|
US7488745B2
(en)
|
2004-07-16 |
2009-02-10 |
Schering Corporation |
Compounds for the treatment of inflammatory disorders
|
|
US7504424B2
(en)
|
2004-07-16 |
2009-03-17 |
Schering Corporation |
Compounds for the treatment of inflammatory disorders
|
|
US7138423B2
(en)
|
2004-07-20 |
2006-11-21 |
Bristol-Myers Squibb Company |
Arylpyrrolidine derivatives as NK-1 /SSRI antagonists
|
|
US7098203B2
(en)
|
2004-07-20 |
2006-08-29 |
Bristol-Myers Squibb Company |
Homopiperidine derivatives as NK-1 antagonists
|
|
GB0519957D0
(en)
|
2005-09-30 |
2005-11-09 |
Sb Pharmco Inc |
Chemical compound
|
|
US7872023B2
(en)
|
2005-02-17 |
2011-01-18 |
Research Triangle Institute |
Kappa opioid receptor ligands
|
|
TW200804307A
(en)
|
2005-10-27 |
2008-01-16 |
Synta Pharmaceuticals Corp |
Process for preparing mesylate salts of IL-12 inhibitory compounds
|
|
EP1957450B1
(en)
|
2005-12-01 |
2009-06-24 |
F.Hoffmann-La Roche Ag |
Serotonin transporter (sert) inhibitors
|
|
US20070142389A1
(en)
|
2005-12-20 |
2007-06-21 |
Pfizer Inc. |
Piperidine derivatives
|
|
CA2646430A1
(en)
|
2006-03-14 |
2007-09-20 |
Amgen Inc. |
Bicyclic carboxylic acid derivatives useful for treating metabolic disorders
|
|
WO2008012623A1
(en)
|
2006-07-25 |
2008-01-31 |
Pfizer Products Inc. |
Benzimidazolyl compounds as potentiators of mglur2 subtype of glutamate receptor
|
|
DK2101740T3
(da)
|
2006-12-04 |
2013-11-18 |
Orexo Ab |
Nye ikke-misbrugs-farmaceutiske sammensætninger omfattende opioider
|
|
WO2008139484A2
(en)
|
2007-05-16 |
2008-11-20 |
R. L. Fine Chem |
New process for the synthesis of loferpramine maleate: a stable salt of loferpramine
|
|
TWI443090B
(zh)
|
2007-05-25 |
2014-07-01 |
Abbvie Deutschland |
作為代謝性麩胺酸受體２（ｍｇｌｕ２ 受體）之正向調節劑之雜環化合物
|
|
US8962841B2
(en)
|
2007-06-29 |
2015-02-24 |
Brock University |
Methods for one-pot N-demethylation/N-functionalization of morphine and tropane alkaloids
|
|
BRPI0815658A2
(pt)
|
2007-08-07 |
2015-02-18 |
Hoffmann La Roche |
Aril-éter pirrolidina como antagonistas do receptor nk3
|
|
CN101861302A
(zh)
|
2007-08-22 |
2010-10-13 |
弗·哈夫曼-拉罗切有限公司 |
作为nk3受体拮抗剂的吡咯烷芳基-醚
|
|
GB0721178D0
(en)
*
|
2007-10-29 |
2007-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
KR20100103799A
(ko)
|
2007-11-16 |
2010-09-28 |
네우렉슨 인코포레이티드 |
내장통을 치료하기 위한 인돌 화합물 및 방법
|
|
TW200930713A
(en)
|
2007-12-03 |
2009-07-16 |
Takeda Pharmaceutical |
Nitrogen-containing heterocyclic compound and use thereof
|
|
US8394834B2
(en)
|
2009-08-25 |
2013-03-12 |
Hoffman-La Roche Inc. |
Pyrrolidines as NK3 receptor antagonists
|
|
RU2568434C2
(ru)
|
2009-10-30 |
2015-11-20 |
Янссен Фармацевтика Нв |
Пиримидиновые соединения для использования в качестве модуляторов дельта-опиоидных рецепторов
|
|
BR112012012905A2
(pt)
|
2009-12-04 |
2017-03-01 |
Hoffmann La Roche |
derivados de difenil azepina como inibidores da reabsorção de monoamina
|
|
US8664214B2
(en)
|
2010-03-30 |
2014-03-04 |
AbbVie Deutschland GmbH & Co. KG |
Small molecule potentiators of metabotropic glutamate receptors I
|
|
US8507535B2
(en)
|
2010-07-07 |
2013-08-13 |
Hoffmann-La Roche Inc. |
Methyl-pyrrolidine ether derivatives
|
|
WO2012075232A1
(en)
|
2010-12-04 |
2012-06-07 |
Trevena, Inc. |
Opioid receptor ligands and methods of using and making the same
|
|
JP6133790B2
(ja)
|
2011-02-18 |
2017-05-24 |
ザ スクリプス リサーチ インスティテュート |
ミエリン形成細胞運命へのオリゴデンドロサイト前駆細胞の定方向分化
|
|
ME02754B
(me)
*
|
2011-03-23 |
2018-01-20 |
Trevena Inc |
Ligandi opioidnih receptora i postupci njihove upotrebe i pripreme
|
|
WO2012129562A2
(en)
|
2011-03-24 |
2012-09-27 |
The Scripps Research Institute |
Compounds and methods for inducing chondrogenesis
|
|
JP2014159375A
(ja)
|
2011-06-15 |
2014-09-04 |
Takeda Chem Ind Ltd |
アゼパン化合物
|
|
RU2629116C2
(ru)
|
2011-10-14 |
2017-08-24 |
Эррэй Биофарма Инк. |
Полиморфы arry-380, селективного ингибитора erbb2, и фармацевтические составы, содержащие их
|
|
RU2014121984A
(ru)
|
2011-10-31 |
2015-12-10 |
Ксенон Фармасьютикалз Инк. |
Бензолсульфонамидные соединения и их применение в качестве терапевтических средств
|
|
ES2576082T3
(es)
|
2012-01-31 |
2016-07-05 |
Eisai R&D Management Co., Ltd. |
Derivado de paroxetina
|
|
WO2013182612A1
(en)
|
2012-06-07 |
2013-12-12 |
Bayer Pharma Aktiengesellschaft |
Glucose transport inhibitors
|
|
MX363480B
(es)
*
|
2012-08-10 |
2019-03-22 |
Janssen Sciences Ireland Uc |
Compuestos bacterianos que constan de un grupo heterocicloalquilo basado en nitrógeno que contiene un doble enlace unido a carbonilo que inhiben la enzima fabi.
|
|
CN105209457A
(zh)
|
2013-03-15 |
2015-12-30 |
艾伯维德国有限责任两合公司 |
吡咯烷衍生物，含有其的药物组合物及其在治疗中的用途
|
|
US9765027B2
(en)
*
|
2014-08-22 |
2017-09-19 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Substituted 1-arylethyl-4-acylaminopiperidine derivatives as opioid/alpha-adrenoreceptor modulators and method of their preparation
|
|
ES2913117T3
(es)
|
2015-06-26 |
2022-05-31 |
Univ Michigan Regents |
Inhibidores de quinasa receptora acoplada a proteína G y métodos para el uso de los mismos
|
|
PT3344248T
(pt)
*
|
2015-09-02 |
2022-06-29 |
Trevena Inc |
Compostos moduladores do recetor opioide delta contendo aza-heterocíclicos de 6 membros, composições compreendendo os mesmos e seus usos
|
|
US11225487B2
(en)
|
2017-02-17 |
2022-01-18 |
Trevena, Inc. |
7-membered aza-heterocyclic containing δ-opioid receptor modulating compounds, methods of using and making the same
|
|
BR112019016827A2
(pt)
*
|
2017-02-17 |
2020-04-07 |
Trevena Inc |
compostos moduladores de receptor delta-opioide contendo aza-heterocíclico com 5 membros, métodos de uso e produção dos mesmos
|
|
IL271149B2
(en)
*
|
2017-06-14 |
2024-05-01 |
Trevena Inc |
Compounds for modulating s1p1 activity and methods of using the same
|
|
CA3079273A1
(en)
|
2017-10-18 |
2019-04-25 |
Epizyme, Inc. |
Amine-substituted heterocyclic compounds as ehmt2 inhibitors, salts thereof, and methods of synthesis thereof
|
|
CN111138425A
(zh)
|
2020-01-06 |
2020-05-12 |
中国药科大学 |
三氮唑类衍生物及其制备方法与用途
|
|
JP2023546729A
(ja)
|
2020-10-27 |
2023-11-07 |
トレベナ・インコーポレイテッド |
デルタオピオイドモジュレーターの結晶形及び非晶形
|
|
WO2023070605A1
(en)
|
2021-10-29 |
2023-05-04 |
Trevena, Inc. |
Methods of preparing 6-membered aza-heterocyclic containing delta-opioid receptor modulating compounds
|